Clinical Trials Logo

Premature Birth clinical trials

View clinical trials related to Premature Birth.

Filter by:

NCT ID: NCT05503238 Not yet recruiting - Preterm Infant Clinical Trials

The Effects of Mother-infant Skin-to-skin Contact on Stress Response of Preterm Infants

Start date: December 1, 2023
Phase: N/A
Study type: Interventional

This study will evaluate the effect of maternal-infant skin-to-skin contact (SSC) versus routine care on general stress in preterm infants in the neonatal intensive care unit (NICU).

NCT ID: NCT05502510 Completed - Pregnancy Related Clinical Trials

Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application

Start date: September 23, 2019
Phase:
Study type: Observational

One in ten births will occur prior to 37 weeks of gestation leading to serious complications such as problems with lung, heart and brain function and an increased risk of infant mortality. Solutions exist to treat risk factors related to preterm birth but these solutions require timely identification of the risks which is often not possible within regular prenatal care. This study will evaluate MyHealthyPregnancy, an application that monitors for common risks associated with preterm birth and recommends solutions to the expectant mother and care team.

NCT ID: NCT05501938 Recruiting - Preterm Birth Clinical Trials

Physical Exam Indicated Cerclage in Singleton Gestation 24 Weeks to 25 Weeks and 6 Days Gestation

Start date: August 11, 2022
Phase: N/A
Study type: Interventional

RCT assessing preterm delivery rate in singleton pregnancies having a physical-exam indicated cerclage placed between 24 weeks and 25 weeks and 6 days. Patients randomized to either cerclage intervention or routine standard of care (no cerclage).

NCT ID: NCT05498753 Not yet recruiting - Preterm Birth Clinical Trials

Development, ADL, Participation, and Quality of Life in Preterm Infants: A Longitudinal Follow Up Study

Start date: February 21, 2023
Phase:
Study type: Observational

A Longitudinal Study of Function, ADL, and Quality of life of Patients with Developmental Disabilities

NCT ID: NCT05496790 Recruiting - Clinical trials for Cardiovascular Diseases

Role of LipoprotEin(a) in CardiovascuLar Diseases and Premature Acute Coronary Syndromes - (RELACS) Study

RELACS
Start date: January 1, 2021
Phase:
Study type: Observational [Patient Registry]

Several clinical and preclinical studies have focused interest on lipoprotein(a) [Lp(a)], showing a direct and independent relationship of its circulating levels with the progression of atherosclerosis and its clinical manifestations. However, to date, Lp(a) represents an underestimated predictor of CV risk, especially in higher-risk populations, such as patients with strong CV familiarity and recurrent and/or early-onset CV events. The key point of the project will be the evaluation of the role of Lp(a) in the development of atherosclerotic disease and, specifically, acute coronary syndrome.

NCT ID: NCT05496400 Completed - Premature Clinical Trials

Anemia of Prematurity and Hemodynamics

Start date: July 1, 2021
Phase:
Study type: Observational

The aim of this work to study the hemodynamic changes accompanying anemia of prematurity in neonates with gestational age ≤32 weeks and the effect of its treatment on hemodynamics.

NCT ID: NCT05493540 Completed - Clinical trials for Patent Ductus Arteriosus After Premature Birth

Oral Ibuprofen Versus Placebo in Treatment of Patent Ductus Arteriosus (PDA)in Preterm Infants

Start date: April 15, 2021
Phase: Phase 2
Study type: Interventional

The management options of Patent Ductus Arteriosus are still controversial and differ between centers. Recently, conservative management has been gaining interest as the evidence of benefit from medical treatment in terms of mortality and morbidity is lacking. This study will compare oral ibuprofen (the standard treatment) with the conservative treatment, in terms of ductal closure and morbidity and mortality at discharge in preterm neonates less than 34 weeks.

NCT ID: NCT05492747 Completed - Premature Infants Clinical Trials

Kangaroo Care an EffectonTransitionTime From Gavage Feeding

KangarooCare
Start date: January 3, 2019
Phase: N/A
Study type: Interventional

Objectives: Kangaroo care is a safe and effective alternative method to conventional neonatal care for newborn babies. The aim of this study was to evaluate the effect of kangaroo care on the transition time to full oral feeding in preterm infants fed by gavage. Methods: This is a randomized controlled trial. This study was conducted in a level III neonatal intensive care unit of a university hospital in eastern Turkey 50 premature babies with a birth weight of ≥ 1000 g and a gestational age of 27-36 weeks, and their mothers were included in the study. The cases were randomly divided into two groups: kangaroo care, which would be applied up to five days a week, and standard care. Records of cases were kept regularly from their hospitalization until they reached full oral feeding.

NCT ID: NCT05490173 Not yet recruiting - Premature Birth Clinical Trials

The Pilot Experimental Study of the Neuroprotective Effects of Exosomes in Extremely Low Birth Weight Infants

Start date: October 5, 2022
Phase: N/A
Study type: Interventional

To study the safety and efficacy of intranasal administration of exosomes derived from mesenchymal stromal cells on long-term neurodevelopmental outcome in extremely low birth weight infants born at gestational age 25/0-27/6 weeks.

NCT ID: NCT05485610 Recruiting - Clinical trials for Diminished Ovarian Reserve

Effect of NMN (Nicotinamide Mononucleotide) on Diminished Ovarian Reserve (Including Premature Ovarian Insufficiency)

Start date: July 1, 2022
Phase: N/A
Study type: Interventional

The purpose of the study is to understand the effect of nicotinamide mononucleotide (NMN) on patients with diminished ovarian reserve (including premature ovarian insufficiency).